# Kynos Therapeutics Ltd

## Details

- **Company number:** [12501037](https://find-and-update.company-information.service.gov.uk/company/12501037)
- **Status:** Liquidation
- **Type:** Private Limited Company
- **Incorporated:** 5 Mar 2020
- **Registered office:** UNIT K BOURNE END BUSINESS PARK, CORES END ROAD, BOURNE END, SL8 5AS
- **Nature of business:** [72110](/sic/72110) Research and experimental development on biotechnology




## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Professor Scott Peter Webster | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 5 Mar 2020 | 3 Feb 2022 |
| Professor Damian James Mole | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 5 Mar 2020 | 3 Feb 2022 |
| Dr. Martin Falk | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 28 Oct 2024 |  |



## Accounts

| Year ended | Net assets | Employees |
|---|---|---|
| 31 Dec 2021 | -£21,006 | 0 |
| 31 Mar 2021 | £2,240 | 2 |






## Companies at the same address

- [DR. Falk Pharma UK Limited](/company/02307698) (02307698)